Vol 8, No 4 (2007): Practical Diabetology
Other materials agreed with the Editors
Published online: 2007-05-17
Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes. Prevention of fluid retention
Diabetologia Praktyczna 2007;8(4):135-146.
Abstract
Not available
Keywords: rosiglitazonefenofibratediabetes type 2FFA level